Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Piotr Bernaczyk is active.

Publication


Featured researches published by Piotr Bernaczyk.


Folia Histochemica Et Cytobiologica | 2010

Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer.

Bozena Dobrzycka; Terlikowski S; Magdalena Garbowicz; Wieslawa Niklinska; Piotr Bernaczyk; Jacek Niklinski; Maciej Kinalski; Lech Chyczewski

The aim of the present study was to characterize the expression pattern of tumor necrosis factor (TNF)-alpha and its receptors (TNF-Rs) in the epithelial ovarian cancer (EOC) and compare these results with the outcome of 126 patients. Presence of TNF-alpha, TNFR-1 and TNFR-2 were studied by Western blotting and immunohistochemistry. The proportion of samples positive for TNF-alpha and TNF-R2 was higher in epithelial ovarian cancer patients than in benign ovarian diseases (p<0.001 and p=0.016, respectively). Immunostaining intensity of TNF-R2 were correlated with tumor stage (p<0.001) and with reduced mean survival time (MST) (p=0.002). The results of the present study suggested that tissue expression of TNF-R2 in epithelial ovarian cancer was correlated with the highest risk of cancer progression. Thus, the clinical value of activated TNF system in epithelial ovarian cancer needs to be further investigated.


Photodiagnosis and Photodynamic Therapy | 2014

Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia.

Małgorzata Pietruska; Stefan Sobaniec; Piotr Bernaczyk; Magdalena Cholewa; Jan Pietruski; Ewa Dolińska; Anna Skurska; Ewa Duraj; Grażyna Tokajuk

BACKGROUND The aim of the study was clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia lesions. METHODS Twenty-three consecutive patients aged 21-79 were included to the study. In all patients 44 homogeneous, flat leukoplakia lesions were clinically diagnosed and confirmed histopathologically. Photodynamic therapy was performed with the use of Photolon(®) photosensitizer, containing 20% Chlorine-e6 and 10% dimethyl sulfoxide and a semiconductor laser, with power up to 300mW and a wavelength of 660nm. Ten illumination sessions were conducted with the use of superficial light energy density of 90J/cm(2). RESULTS At baseline the mean size of leukoplakia lesion was 6.5±5.10cm(2) while after photodynamic therapy 3±2.99cm(2). Significant reduction (on average by 53.8%) of leukoplakia lesions sizes was observed after therapy. Twelve (27.27%) lesions had been completely cured, 22 (50%) partially cured, although 10 (22.73%) lasted unchanged. The efficacy of PTD was comparable in women and men irrespective of age. There have been no adverse site effects during therapy noted. CONCLUSIONS Within the limits of the study it can be concluded that photodynamic therapy with the use of Chlorine-e6 can lead to considerable reduction of oral leukoplakia lesions size thus may be useful in clinical practice. However there is a need of further studies on larger number of cases and longer follow-up time.


The Journal of Clinical Endocrinology and Metabolism | 2016

Functional Expression of FSH Receptor in Endometriotic Lesions.

Donata Ponikwicka-Tyszko; Marcin Chrusciel; Joanna Stelmaszewska; Piotr Bernaczyk; Maria Sztachelska; Iwona Sidorkiewicz; Milena Doroszko; Jakub Tomaszewski; Juha S. Tapanainen; Ilpo Huhtaniemi; Slawomir Wolczynski; Nafis A. Rahman

CONTEXT FSH receptor (FSHR), besides being expressed in gonads, is also expressed in some extragonadal tissues at low levels. OBJECTIVE We examined the functional expression of FSHR in different types of endometriotic lesions. DESIGN Extensive studies were carried out to detect functional FSHR expression and FSH-stimulated estrogen production in ovarian endometriomas and recto-vaginal endometriotic nodules (RVEN). Normal endometrium, ovary, and myometrium tissues from nonpregnant cycling women served as controls. SETTINGS This laboratory-based study was carried out on tissue specimens from patients with endometriosis and healthy donors. RESULTS Endometriotic lesions and normal secretory-phase endometrium showed FSHR expression at both mRNA and protein level. RVEN and ovarian endometrioma demonstrated up-regulated CYP19A1, dependent on the activation of CYP19A1 proximal promoter II. Estrogen receptor-β (ESR2) expression was significantly increased in RVEN vs normal endometrium. Recombinant human FSH stimulation of RVEN explants significantly increased estradiol production and CYP19A1 and ESR2 expression. FSHR was up-regulated in recombinant human FSH-stimulated endometrial and decidualized stromal cells with increased CYP19A1 expression. CONCLUSIONS We described a novel functional FSHR expression, where FSH-stimulated CYP19A1 expression and estrogen production in RVEN are demonstrated. This locally FSH-induced estrogen production may contribute to the pathology, development, progression, and severity of RVEN.


Folia Histochemica Et Cytobiologica | 2011

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer

Bozena Dobrzycka; Terlikowski S; Piotr Bernaczyk; Magdalena Garbowicz; Jacek Niklinski; Lech Chyczewski; Marek Kulikowski

Apoptosis may occur via a death receptor-dependent or independent (mitochondrial) pathway. The mitochondrial pathway is regulated by small molecules, such as smac/Diablo, which activates caspase cascades. This study examined smac/DIABLO expression in 76 patients with endometrioid endometrial cancers. Presence of smac/DIABLO was quantified by Western blot analysis using nonfixed fresh frozen tissues. Its appearance was found in 55 (72%) of examined tumors. Smac/DIABLO expression significantly correlated with tumor grade (p<0.001). Patients with positive smac/DIABLO tumors had a longer disease-specific survival when compared with those with negative tumors in the 10-year follow-up (p=0.043). The study demonstrated that negative smac/DIABLO expression was a poor prognostic sign.


International Journal of Cardiology | 2016

Interleukin 6 modulates PPARα and PGC-1α and is involved in high-fat diet induced cardiac lipotoxicity in mouse.

Tomasz Bonda; Beata Szynaka; Magdalena Sokołowska; Magdalena Dziemidowicz; Ewa Waszkiewicz; Maria M. Winnicka; Piotr Bernaczyk; Natalia Wawrusiewicz-Kurylonek; Karol A. Kamiński

BACKGROUND Interleukin 6 (IL-6) may be involved in regulation of cardiac lipid metabolism and mitochondrial function through its influence on peroxisome proliferator-activated receptors (PPARs). In this study we evaluated the impact of the physiological level of IL-6 on the expression of PPARα and PGC-1α in the heart and the effect of lack of this cytokine on high-fat diet (HFD) induced lipotoxicity. METHODS Male C57BL6/J wild type (WT) and IL-6 knock-out (IL-6KO) mice were used. 20 animals of each genotype were fed with HFD for 15-18weeks. Cardiac function was assessed using echocardiography and cardiomyocyte ultrastructure was examined using electron microscopy. QT-PCR and Western blotting were applied to estimate the expression of PPARα and PGC-1α at the transcriptional and protein levels. RESULTS At baseline WT and IL-6KO mice had similar size and function of the left ventricle. HFD induced similar left ventricular hypertrophic response in both groups without causing heart failure, but only WT animals had increased resting ejection fraction of the LV. Ultrastructure of HFD groups showed markers of lipotoxicity, that were more pronounced in IL-6KO group. In basal conditions IL-6KO animals had lower PPARα and similar PGC-1α expression as compared to WT. HFD induced downregulation of both PPARα and PGC-1α in WT animals, while in IL-6KO mice this effect was constrained. CONCLUSION IL-6 is involved in basal regulation of PPARα and PGC-1α expression in cardiomyocytes. The lack of this cytokine promotes high-fat diet induced lipotoxicity but without overt manifestations of cardiac failure.


Medical Science Monitor | 2011

c-erbB-2 protein expression in astrocytic tumors of the brain

Joanna Reszec; Piotr Bernaczyk; Robert Milewski; Lech Chyczewski; Zenon Mariak

Summary Background Astrocytic tumors are the primary brain tumors, which often progress to glioblastoma, a highly malignant neoplasm of the central nervous system. There is much new data regarding to the formation and progression of these tumors; however, glioblastoma remains one of the most fatal neoplasms in humans. The aim of the study was to evaluate the role of c-erbB-2 protein expression in various groups of astrocytic tumors. Material/Methods 65 cases of astrocytic tumors were divided into 3 groups: diffuse astrocytoma (group I; n=17 cases), anaplastic astrocytoma (group II; n=23 cases) and glioblastoma (group III; n=25 cases). C-erbB-2 protein expression was estimated semiquantitatively on immunohistochemically stained tissue sections using antibodies against c-erbB-2 protein. Statistical analysis was performed in all examined groups. Results The c-erbB-2 protein expression was observed in 15 out of 17 cases (88.3%) in group I, 22 out of 25 cases (88%) cases in group II, and in 19 out of 23 cases (82.6%) in group III. There were no statistically significant differences between the examined groups. The strongest c-erbB-2 immunoexpression was observed in low grade astrocytomas (diffuse astrocytomas G2); in the glioblastoma group the c-erbB-2 protein expression was weak and 17.4% of cases were negative. Conclusions C-erbB-2 protooncogene alteration is an early phenomenon in glial tumor development and progression.


Folia Histochemica Et Cytobiologica | 2012

HIF-1 expression in retinal ganglion cells and optic nerve axons in glaucoma

Joanna Reszec; Renata Zalewska; Piotr Bernaczyk; Lech Chyczewski

Glaucoma is a result of increased intraocular pressure leading to damage to retinal ganglion cells and optic nerve axons. The aim of this study was to evaluate HIF-1 expression in optic nerve axons and retinal ganglion cells in 42 eyes enucleated because of complete glaucoma compared to eyes removed because of injury. The immunohistochemical reaction was done and specimens were examined under a light microscope. 57% of cases presented HIF-1 expression in the optic nerve axons, and 52.3% in the retinal ganglion cells. 20 out of 42 (47.6%) cases were HIF-1 positive both in the optic nerve axons and in the retinal ganglion cells, and the staining was evident mostly in the nuclear and perinuclear area. Our present results indicate that HIF-1 expression in hypoxic conditions in glaucoma might be a very crucial stage in damage to retinal ganglion cells and optic nerve axons, and might be a successful target for the implementation of neuroprotective drugs.


Folia Histochemica Et Cytobiologica | 2011

The evaluation of human papillomavirus and p53 gene mutation in benign and malignant conjunctiva and eyelid lesions.

Reszec Joanna; Zalewska Renata; Pepiński Witold; Skawronska Małgorzata; Piotr Bernaczyk; Lech Chyczewski

Papillomas and squamous cell carcinomas are the most common conjunctival and eyelid lesions. The etiology is still unclear and recently human papillomavirus infection and p53 gene mutation have been taken into consideration. The aim of our study was the evaluation of HPV DNApresence and p53 gene mutation in 45 benign and 38 malignant squamous lesions of the conjunctiva and eyelid. For HPV detection PCR-RFLP and immunohistochemical reaction were used; for p53 gene mutation PCR-SSCP was used. Only 8.8% papillomas, 9.1% squamous cell cancers and 3.7% basal cell cancers (using PCR-RFLP method) and 26.6% papillomas, 7.4% squamous cell cancers and 9.1% basal cell cancers (using immunohisto-chemical reaction) were HPV positive. p53 gene mutation was evaluated in 24.4% papillomas, 54.5% squamous cell cancers and 22.2% basal cell cancers; most commonly in 6 and 7 exon. Human papillomavirus infection, opposite to p53 gene mutation, is not a significant etiological factor of the benign and malignant conjunctival and eyelid lesions development.


Current Gynecologic Oncology | 2015

Histerektomia brzuszna – przestrzenny model chirurgicznej resekcji tkankowej

Michał Zdrodowski; Paweł Knapp; Alicja Szyłejko; Piotr Bernaczyk

The paper presents current views on radical hysterectomy classification, including descriptive comments regarding the surgical extent and medical indications. Radical...


Lasers in Medical Science | 2013

Clinical assessment of the efficacy of photodynamic therapy in the treatment of oral lichen planus.

Stefan Sobaniec; Piotr Bernaczyk; Jan Pietruski; Magdalena Cholewa; Anna Skurska; Ewa Dolińska; Ewa Duraj; Grażyna Tokajuk; Agnieszka Paniczko; Ewa Olszewska; Małgorzata Pietruska

Collaboration


Dive into the Piotr Bernaczyk's collaboration.

Top Co-Authors

Avatar

Lech Chyczewski

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Bozena Dobrzycka

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Joanna Reszec

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Terlikowski S

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacek Niklinski

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Slawomir Wolczynski

Medical University of Białystok

View shared research outputs
Top Co-Authors

Avatar

Maciej Kinalski

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wieslawa Niklinska

Medical University of Białystok

View shared research outputs
Researchain Logo
Decentralizing Knowledge